How to Treat Benign Diseases - Experiences of the German Cooperative Group on Benign Diseases (GCG-BD)
The activity gives an overview of irradiation of benign diseases. The worldwide unique evidence-based S2-guideline of the German Society for Radiation Oncology (DEGRO) that has been translated into English is also presented.
Category
  • Nonmalignant RT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
eContouring for Functional Radiation Medicine - Osteoarthritis and Fibromatosis Webinar
This activity will review benefit of contouring for non-malignant functional radiation therapy with a focus on osteoarthritis and fibromatosis. It will review a typical joint case with anatomy and GTV and PTV consideration and the benefit ofimaging in the setting of fibromatosis.
Category
  • Nonmalignant RT
Format
  • Upcoming Webinar
  • Webinars
  • eContouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $179.00
From Beam to Bedside: Benefits and Logistics of a Dedicated Palliative Radiation Therapy Service
Palliative radiotherapy remains an unmet need, despite its efficacy. The presenter discusses how a dedicated palliative radiation service can address barriers to care and play an integral role in improving care access and receipt.
Category
  • General RO
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $149.00
Pharmacologic Symptom Management in the Radiation Oncology Clinic
Radiation oncologists see patients across a wide spectrum of oncologic diseases and clinical conditions. Whether as a result of disease burden, cancer-directed treatment, or other unrelated problems, many patients present to radiation oncology clinic with significant symptom management needs.
Category
  • General RO
  • Palliative Care
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
Cost $149.00
Definitive Treatment in Transition: De-Escalation, Biomarkers and Immunotherapy in Head and Neck Radiation Oncology
Immunotherapy has transformed the care of patients with recurrent/metastatic head and neck cancer but integration into definitive management has been more challenging.
Category
  • Head and Neck
  • Immunotherapy
Format
  • onDemand
  • Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages